REG - Tristel PLC - Issue of Equity
RNS Number : 3225GTristel PLC05 November 2018
Tristel plc
("Tristel" or the "Company")
Issue of Equity
Tristel plc (AIM: TSTL), the manufacturer of infection prevention, contamination control and hygiene products, announces that, following the exercise of options by an employee, it has issued and allotted 30,000 new ordinary shares of 1 penny each in the Company ("Ordinary Shares"). Application has been made for the new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 9 November 2018.
The new Ordinary Shares will rank pari passu with the existing shares of the Company. Following the exercise of options, the Company's issued share capital consists of 43,730,048 Ordinary Shares. Accordingly, the figure of 43,730,048 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.
For further information please contact:
Tristel plc
Tel: 01638 721 500
Paul Swinney, Chief Executive Officer
Liz Dixon, Finance Director
Walbrook PR Ltd
Tel: 020 7933 8780 or tristel@walbrookpr.com
Paul McManus
Mob: 07980 541 893
Lianne Cawthorne
Mob: 07854 391 303
finnCap
Tel: 020 7220 0500
Geoff Nash (Corporate Finance)
Giles Rolls (Corporate Finance)
Alice Lane (Corporate Broking)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDIOEGIBDBDXGBGIU
Recent news on Tristel
See all newsREG - Tristel PLC - Notice of Preliminary Results
AnnouncementREG - AIM - AIM Notice - 24/09/2024
AnnouncementREG - Tristel PLC - Director/PDMR Shareholding
AnnouncementREG - Tristel PLC - Exercise of Share Options and Total Voting Rights
AnnouncementREG - Tristel PLC - FDA 510(k) submission for Tristel OPH
Announcement